Telomir Pharmaceuticals (TELO) Institutional Ownership $1.68 +0.09 (+5.31%) As of 02:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Telomir Pharmaceuticals (NASDAQ:TELO)Number ofInstitutional Buyers(last 12 months)23TotalInstitutional Inflows(last 12 months)$4.11MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$408.35K Get TELO Insider Trade Alerts Want to know when executives and insiders are buying or selling Telomir Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data TELO Institutional Buying and Selling by Quarter Telomir Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025Jane Street Group LLC49,556$62K0.0%N/A0.167% 8/14/2025Qube Research & Technologies Ltd26,509$33K0.0%N/A0.089% 8/13/2025Marshall Wace LLP75,770$95K0.0%N/A0.255% 8/8/2025Geode Capital Management LLC196,880$246K0.0%-54.1%0.662% 8/1/2025Y Intercept Hong Kong Ltd64,423$81K0.0%N/A0.216% 6/27/2025Goldman Sachs Group Inc.32,282$104K0.0%-36.1%0.108% 5/16/2025Goldman Sachs Group Inc.32,282$104K0.0%-36.1%0.108% 5/13/2025HighTower Advisors LLC43,000$139K0.0%N/A0.144% 5/12/2025Nuveen LLC24,990$81K0.0%N/A0.084% 4/29/2025Bank of New York Mellon Corp91,353$295K0.0%+26.4%0.307% Get the Latest News and Ratings for TELO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Nuveen Asset Management LLC24,990$103K0.0%N/A0.084% 2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.10,699$44K0.0%+279.4%0.036% 2/17/2025Gotham Asset Management LLC6,770$28K0.0%N/A0.023% 2/17/2025Bank of America Corp DE14,713$61K0.0%+283.9%0.049% 2/14/2025Northern Trust Corp151,628$625K0.0%+211.5%0.510% 2/14/2025Transce3nd LLC28,803$119K0.0%N/A0.097% 2/13/2025Barclays PLC29,959$123K0.0%+326.9%0.101% 2/13/2025Wells Fargo & Company MN10,044$41K0.0%+458.3%0.034% 2/12/2025Geode Capital Management LLC413,677$1.71M0.0%+73.3%1.390% 2/12/2025JPMorgan Chase & Co.41,444$171K0.0%+1,096.4%0.139% 2/11/2025Corebridge Financial Inc.9,613$40K0.0%+273.8%0.032% 2/11/2025Virtu Financial LLC14,959$62K0.0%N/A0.050% 2/6/2025Charles Schwab Investment Management Inc.46,406$191K0.0%+327.7%0.157% 2/4/2025Bank of New York Mellon Corp72,295$298K0.0%+40.8%0.244% 1/30/2025Rhumbline Advisers8,600$35K0.0%+105.9%0.029% 11/19/2024Barclays PLC7,018$45K0.0%+325.1%0.024% 11/16/2024Geode Capital Management LLC238,737$1.53M0.0%+259.8%0.806% 11/15/2024Barclays PLC7,018$45K0.0%+325.1%0.024% 11/15/2024State Street Corp36,094$232K0.0%+99.1%0.122% 10/21/2024Suncoast Equity Management51,194$329K0.0%+109.9%0.173% 8/15/2024Beaird Harris Wealth Management LLC14,623$70K0.0%+212.9%0.049% 7/26/2024Bank of New York Mellon Corp50,165$241K0.0%N/A0.169% 5/2/2024Suncoast Equity Management24,391$126K0.0%N/A0.082% (Data available from 1/1/2016 forward) TELO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TELO shares? During the previous two years, 25 institutional investors and hedge funds held shares of Telomir Pharmaceuticals. The most heavily invested institutionals were Northern Trust Corp ($625K), Suncoast Equity Management ($329K), Bank of New York Mellon Corp ($295K), Geode Capital Management LLC ($246K), State Street Corp ($232K), Charles Schwab Investment Management Inc. ($191K), and JPMorgan Chase & Co. ($171K).Learn more on Telomir Pharmaceuticals' institutional investors. Which institutional investors have been buying Telomir Pharmaceuticals' stock? Of the 24 institutional investors that purchased Telomir Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($347.32K), Northern Trust Corp ($102.95K), Bank of New York Mellon Corp ($90.15K), Marshall Wace LLP ($75.77K), Y Intercept Hong Kong Ltd ($64.42K), Suncoast Equity Management ($51.19K), and Jane Street Group LLC ($49.56K). How much institutional buying is happening at Telomir Pharmaceuticals? Institutional investors have bought a total of 1,040,479 shares in the last 24 months. This purchase volume represents approximately $4.11M in transactions. Which of Telomir Pharmaceuticals' major shareholders have been selling company stock? The following institutional investors have sold Telomir Pharmaceuticals stock in the last 24 months: Geode Capital Management LLC ($232.37K), and Goldman Sachs Group Inc. ($36.50K). How much institutional selling is happening at Telomir Pharmaceuticals? Institutional investors have sold a total of 268,868 shares in the last 24 months. This volume of shares sold represents approximately $408.35K in transactions. Related Companies Innate Pharma Major Shareholders Milestone Pharmaceuticals Major Shareholders Forte Biosciences Major Shareholders Corbus Pharmaceuticals Major Shareholders Alto Neuroscience Major Shareholders Cassava Sciences Major Shareholders Genelux Major Shareholders Eledon Pharmaceuticals Major Shareholders Invivyd Major Shareholders Actuate Therapeutics Major Shareholders This page (NASDAQ:TELO) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNvidia CEO shares biggest regret?Earlier this year I predicted that the only reason Elon was in Washington was to push an AI-first agenda. Sinc...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
